Crowe J P, Gordon N H, Antunez A R, Shenk R R, Hubay C A, Shuck J M
Department of Surgery, Case Western Reserve University, Cleveland, OH.
Arch Surg. 1991 Apr;126(4):429-32. doi: 10.1001/archsurg.1991.01410280027002.
Local-regional recurrence patterns were investigated in 1392 patients with breast cancer. Primary treatment for all patients included a mastectomy. Nine hundred seventeen patients had negative nodes and did not receive systemic therapy. Four hundred seventy-five patients had node metastases and were randomized to receive different combinations of chemoendocrine therapy. Follow-up ranged between 5 and 16 years. Two hundred thirty (25.8%) node-negative patients have had recurrences, with the initial recurrence being local-regional in 9.2%. Two hundred forty-two (50.9%) node-positive patients have had recurrences, with the initial recurrence being local-regional in 17.1%. Larger tumors and more extensive node involvement were associated with more first local-regional recurrences. The relative percent of first local-regional recurrence among patients in whom cancer recurred was similar for node-negative and node-positive patients (35.4% and 33.5%, respectively). In 63.6% of patients in whom cancer recurred, first local-regional recurrence were distant. Larger tumors, more extensive node involvement, and a shorter disease-free interval after mastectomy were associated with more rapid appearance of distant recurrence among these patients.
对1392例乳腺癌患者的局部区域复发模式进行了研究。所有患者的初始治疗均包括乳房切除术。917例患者淋巴结阴性,未接受全身治疗。475例患者有淋巴结转移,被随机分配接受不同组合的化疗内分泌治疗。随访时间为5至16年。230例(25.8%)淋巴结阴性患者出现复发,其中9.2%的初始复发为局部区域复发。242例(50.9%)淋巴结阳性患者出现复发,其中17.1%的初始复发为局部区域复发。肿瘤较大和淋巴结受累范围更广与更多的首次局部区域复发相关。在复发的患者中,淋巴结阴性和阳性患者首次局部区域复发的相对百分比相似(分别为35.4%和33.5%)。在63.6%复发的患者中,首次局部区域复发为远处复发。肿瘤较大、淋巴结受累范围更广以及乳房切除术后无病间期较短与这些患者中远处复发的更快出现相关。